Interventional therapy of acute myocardial infarction

被引:2
作者
Zahn, R. [1 ]
Zeymer, U. [1 ]
机构
[1] Herzzentrum Ludwigshafen, D-67063 Ludwigshafen, Germany
来源
INTERNIST | 2008年 / 49卷 / 09期
关键词
acute myocardial infarction; ST-segment elevation myocardial infarction; non-ST-segment elevation myocardial infarction; percutaneous coronary intervention;
D O I
10.1007/s00108-008-2075-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Currently an acute myocardial infarction has to be differentiated into ST-elevation myocardial infarction (STEMI) or non ST-elevation myocardial infarction (NSTEMI). However, there exists another definition of acute coronary syndromes (ACS), which is more important in clinical practice, for all recommendations from the guidelines of the cardiac societies concerning the invasive strategies rely on this one. Here one has to differentiate an ACS with ST-elevation (STE-ACS = STEMI) from an ACS without ST-elevation (NSTE-ACS). The last one is further divided into an NSTE-ACS with or without high risk. In patients with an NSTE-ACS with high risk an early invasive strategy is recommended within 72 h after the diagnosis. In patients with an NSTE-ACS without high risk a more conservative approach can be pursued. In STE-ACS patients primary angioplasty is the reperfusion therapy of choice, if it can be performed in a timely fashion within 2 h after diagnosis at an interventional centre with experienced interventionalists and short "door-to-balloon" times. In Germany this goal is achievable almost everywhere. Therefore it is currently the most important task to establish local networks to reach this goal.
引用
收藏
页码:1038 / 1046
页数:9
相关论文
共 38 条
  • [1] Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
    Alpert, JS
    Antman, E
    Apple, F
    Armstrong, PW
    Bassand, JP
    de Luna, AB
    Beller, G
    Breithardt, G
    Chaitman, BR
    Clemmensen, P
    Falk, E
    Fishbein, MC
    Galvani, M
    Garson, A
    Grines, C
    Hamm, C
    Hoppe, U
    Jaffe, A
    Katus, H
    Kjekshus, J
    Klein, W
    Klootwijk, P
    Lenfant, C
    Levy, D
    Levy, RI
    Luepker, R
    Marcus, F
    Näslund, U
    Ohman, M
    Pahlm, O
    Poole-Wilson, P
    Popp, R
    Pyörälä, K
    Ravkilde, J
    Rehnquist, N
    Roberts, W
    Roberts, R
    Roelandt, J
    Rydén, L
    Sans, S
    Simoons, ML
    Thygesen, K
    Tunstall-Pedoe, H
    Underwood, R
    Uretsky, BF
    de Werf, FV
    Voipio-Pulkki, LM
    Wagner, G
    Wallentin, L
    Wijns, W
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 (18) : 1502 - 1513
  • [2] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
    Andersen, HR
    Nielsen, TT
    Rasmussen, K
    Thuesen, L
    Kelbaek, H
    Thayssen, P
    Abildgaard, U
    Pedersen, F
    Madsen, JK
    Grande, P
    Villadsen, AB
    Krusell, LR
    Haghfelt, T
    Lomholt, P
    Husted, SE
    Vigholt, E
    Kjaergard, HK
    Mortensen, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 733 - 742
  • [3] [Anonymous], 1987, LANCET, V2, P871
  • [4] [Anonymous], 1986, LANCET, V1, P397
  • [5] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [6] Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161
  • [7] Betriu A, 1997, NEW ENGL J MED, V336, P1621
  • [8] Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients
    Boersma, E
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (07) : 779 - 788
  • [9] BRUCKENBERGER E, 2007, 19 BERICHT SEKTORENU
  • [10] Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
    Cannon, CP
    Gibson, CM
    Lambrew, CT
    Shoultz, DA
    Levy, D
    French, WJ
    Gore, JM
    Weaver, WD
    Rogers, WJ
    Tiefenbrunn, AJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (22): : 2941 - +